In the latter case, IL2 produced by the tumor-responsive SynNotch circuit drove autocrine stimulation of the T-cell in a tumor specific, but TCR/CAR independent, manner enabling efficient tumor infiltration and control of an immune-excluded tumor model. This evidence concerns the gene IL2 and neoplasm.